Treating inflammation and inflammatory pain in mucosa using mucosal prolonged release bioadhesive therapeutic carriers
AssigneeOnxeo
InventorsPierre ATTALI, Caroline LEMARCHAND, Vanessa ROULET, Claire SCHEUIR, Lorraine ZAKIN
Life of this patent
Estimating the term…
Abstract
The present invention concerns a pharmaceutical composition comprising an alpha-2 adrenergic receptor agonist for preventing or treating inflammatory pain and diseases in mucosa of oral cavity, pharynx and larynx. In another aspect the present invention provides mucosal bioadhesive slow release carriers for the extended and controlled release of alpha-2 adrenergic receptor agonists that can be used on mucosal surfaces for preventing or treating inflammatory pain and diseases in mucosa of oral cavity.
Claims31
1-15. (canceled)
A method of treating inflammatory disease in oral mucosa comprising administering to a subject in need thereof a pharmaceutical composition comprising a therapeutically effective amount of a first active ingredient selected from clonidine and pharmaceutically acceptable salts thereof.
Dependencies are inferred from the claim text.